Here are the key highlights from today's trading session:

1. Sensex and Nifty close in the green, but off highs

2. Financials continue to drag market, Nifty Bank slips 689 points from highs

3. Sensex falls 544 points from highs to close 167 points higher at 30,196

4. Nifty slips 151 points from highs to close 56 points higher at 8,879

5. Midcap Index ends 62 points higher at 12,471; 171 points off intra-day high

6. PSU Bank top losing index while telecom gains the most

7. Bharti Airtel surges to record high after strong earnings and positive commentary

8. Bharti Airtel expects ARPU to hit Rs 200 in short-term and Rs 300 in long-term

9. Bharti Airtel, HDFC and ITC lift Nifty by 53 points while RIL and HDFC Bank drag by 32 points

10. Multiplex shares gain as states ease lockdown; PVR and Inox Leisure up 8-15%

11. Adani Group stocks gain up to 16%

12. Market breadth favours declines; advance-decline ratio at 3:4

May 19, 2020 3:50 PM

Closing Bell: Indian market hold gains but fall from day's high

Indian equity market ended with gains on Tuesday due to Bharti Airtel, HDFC and ITC. Financials and bank index dragged the index down from its day's high levels. PSU bank index slipped the most while the telecom sector gained the most today on the back of Bharti Airtel. Global markets continued to celebrate gains on the back of Moderna's first successful clinical trial.

On the Nifty50 index, Bharti Airtel, Adani Ports, ONGC, UltraTech Cement and Grasim were the top gainers while UPL, Vedanta, RIL, IndusInd Bank and L&T were the top losers.

May 19, 2020 3:44 PM

May 19, 2020 3:31 PM

Buzzing Stocks: Share price of UPL, Atul, Coromandal International and Rallis India were down up to 6 percent after the Centre has issued a draft order banning sale, use and import of 27 insecticides. The insecticides have been listed for the potential ban, the Ministry of Agricultural and Farmers Welfare said in the draft order dated May 14. Read more here!

May 19, 2020 3:14 PM

Earnings Reaction: Sanofi India's shares traded 0.41 percent lower to Rs 7,438 on the NSE after the company's net profit slipped 8 percent YoY to Rs 85.4 crore during the quarter ended March 2020. However, the revenue rose over 9 percent to Rs 755 crore and EBITDA margin also rose 110 bps to 22.5 percent from 21.4 percent in the same quarter last year.

May 19, 2020 3:00 PM

After negative close last month, WTI crude trades at $30 ahead of expiry

Crude oil prices are up more than 45 percent in May and trading at their highest in two months. It marks quite a comeback ahead of the WTI June contract expiry.Get latest Energy online at cnbctv18.com

May 19, 2020 2:45 PM

Rupee Update: The Indian currency ended higher tracking positive cues from the equity market. The Indian rupee ended at 75.63 against the US dollar as compared to Monday's close of 75.90.

May 19, 2020 2:29 PM

Bharti Airtel looks good in terms of volume, price and open interest pattern, says Kotak Securities

Today's activity is completely mixed but Bharti Airtel looks good given higher volume, price and open interest pattern. The stock has broken its all-time high levels along and the price is also sustaining above the mark of Rs 580. Hence, one can buy the stock with a target price range of Rs 610-615 in next one-two days, said Shrikant Chouhan of Kotak Securities.

The other stock that we are bearish on is Manappuram Finance. The stock is currently trading around Rs 117-118, and has formed a lower-higher formation so we can expect it to move to Rs 108 on the downside but keep a stop loss at Rs 122, added Chouhan.

May 19, 2020 2:15 PM

Stocks Update: Lincoln Pharma gets EU GMP certification from Germany FDA for its manufacturing facility located at Khatraj in Gujarat. The certification will allow the company to market its products in all the 27 member countries of EU and give access to European Economic Area (EEA) countries. At 1:52 pm, the shares rose 2.15 percent to Rs 166 on the NSE.

May 19, 2020 2:00 PM

May 19, 2020 1:45 PM

Motilal Oswal On RIL: Broking house expects RJio to garner revenue/EBITDA CAGR of 22%/44% over FY20-22E along with healthy EBITDA margin expansion. Despite the price hike, the company witnessed lower-than-expected ARPU growth in Q4FY20, which was mainly due to longer validity recharge plans. It believes RJio would accrue full benefit of the price hike in FY21. It has kept buy rating on RIL with a price target of Rs 1,713 per share.

May 19, 2020 1:30 PM

European markets flat despite hopes that a coronavirus vaccine can be found

European stocks opened fractionally higher Tuesday, continuing the positive trend set at the start of the week as hopes rise for a coronavirus vaccine.

The pan-European Stoxx 600 hovered around the flatline in early trade, with bank stocks adding 1 percent to lead gains while the construction sector slid 0.8 percent lower.

DAX traded slightly higher than one percent at 11,182 while FTSE and CAC traded nearly 0.50 percent higher at 6,088 and 4,517 respectively.

European stocks closed sharply higher Monday as investor confidence rose with lockdown restrictions around the world being lifted. A big boost for global markets has also come with hope of a potential coronavirus vaccine after a positive development from a Moderna trial.

May 19, 2020 1:15 PM

AU Small Fin CEO sells shares to repay loan; Govt of Singapore, Sunil Mittal buyers

Sunil Mittal’s Bharti SBM Holdings bought 24 lakh shares, the Government of Singapore bought 19 lakh shares and Monetary Authority of Singapore bought 5.3 lakh shares.Get latest Finance online at…

May 19, 2020 1:00 PM

Stocks Update: Lupin launched the generic version of Bausch Health's Apriso capsules in the U.S. market. The said drug is used in the maintenance of remission of ulcerative colitis in adults, said the company's exchanges filing. Mesalamine Extended-release capsules had an annual sale of about $290 million in the U.S. market as of March 2020. At 12:40 pm, the shares traded 0.46 percent lower at Rs 853 on the NSE.

May 19, 2020 12:45 PM

Retailers fear low footfalls post pandemic

India's grocery and apparel retailers are reassessing store blueprint and strategy during the ongoing coronavirus-forced lockdown in the country. A large number of retailers are of the view that they may have to axe unprofitable stores if footfalls are low.

"We have not decided how many stores we would need to rationalise as yet. If we have multiple stores in a certain locality, we are trying to see if we can axe some in overlapping areas," said a food retailer.

Industry officials believe that retailers could look at rationalising at least 20-30 percent stores in the short-to-medium-term. Read more

May 19, 2020 12:32 PM

Load more